FDA — authorised 25 June 1991
- Application: NDA019851
- Marketing authorisation holder: VALIDUS PHARMS
- Local brand name: LOTENSIN
- Indication: TABLET — ORAL
- Status: approved
FDA authorised ACEI on 25 June 1991
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA authorised it on 25 June 1991; FDA has authorised it.
VALIDUS PHARMS holds the US marketing authorisation.